Sodium lauryl sulphate alters the mRNA expression of lipid-metabolizing enzymes and PPAR signalling in normal human skin in vivo

Experimental Dermatology

Volumn 18, Issue 12, 2009, Pages 1010-1015

  Törmä, Hans ^a   Berne, Berit ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ceramide; Irritant; Lipid metabolism; PPAR; Skin barrier

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE B; CERAMIDE; DODECYL SULFATE SODIUM; GLUCOSYLCERAMIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOXYGENASE; LIPOXYGENASE III; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; WATER;

ADULT; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIPID ANALYSIS; LIPOGENESIS; MALE; NORMAL HUMAN; PROTEIN EXPRESSION; REACTION TIME; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN BIOPSY;

ACETYL-COA CARBOXYLASE; ADULT; ARACHIDONATE 12-LIPOXYGENASE; AZO COMPOUNDS; ENZYMES; EXTRACELLULAR SPACE; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GENE EXPRESSION; GLUCOSYLCERAMIDASE; GLUCOSYLTRANSFERASES; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; LIPOXYGENASE; MALE; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SERINE C-PALMITOYLTRANSFERASE; SIGNAL TRANSDUCTION; SKIN; SODIUM DODECYL SULFATE; SPHINGOMYELIN PHOSPHODIESTERASE; YOUNG ADULT;

EID: 70849091015     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00877.x     Document Type: Article

References (46)

1. Proksch E, Brandner J M, Jensen J M. The skin: an indispensable barrier. Exp Dermatol 2008, 17:1063-1072.
2. Vielhaber G, Pfeiffer S, Brade L. Localization of ceramide and glucosylceramide in human epidermis by immunogold electron microscopy. J Invest Dermatol 2001, 117:1126-1136.
3. Mauro T, Holleran W M, Grayson S. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998, 290:215-222.
4. Willis C, Lindberg M, Forslind B, Lindberg M. Understanding the irritant reaction. Skin, Hair and Nails Structure and Function 2004, 233-272. In, eds, New York, Marcel & Dekker
5. Grängsjö A, Leijon-Kuligowski A, Törmä H, Roomans G M, Lindberg M. Different pathways in irritant contact eczema? Early differences in the epidermal elemental content and expression of cytokines after application of 2 different irritants. Contact Dermatitis 1996, 35:355-360.
6. Grubauer G, Elias P M, Feingold K R. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 1989, 30:323-333.
7. Feingold K R. The regulation of epidermal lipid synthesis by permeability barrier requirements. Crit Rev Ther Drug Carrier Syst 1991, 8:193-210.
8. Feingold K, Elias P, Loden M, Maibach H I. The environmental interface: regulation of permeability barrier homeostasis. Dry Skin and Moisturizers Chemistry and Function 2000, 45-58. In, eds, Boca Raton, CRC Press
9. Proksch E, Holleran W M, Menon G K, Elias P M, Feingold K R. Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 1993, 128:473-482.
10. Proksch E, Feingold K R, Elias P M. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. J Invest Dermatol 1992, 99:216-220.
11. Wei T, Geijer S, Lindberg M, Berne B, Törmä H. Detergents with different chemical properties induce variable degree of cytotoxicity and mRNA expression of lipid-metabolizing enzymes and differentiation markers in cultured keratinocytes. Toxicol In Vitro 2006, 20:1387-1394.
12. Harris I R, Farrell A M, Grunfeld C, Holleran W M, Elias P M, Feingold K R. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 1997, 109:783-787.
13. Komuves L G, Hanley K, Lefebvre A M. Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 2000, 115:353-360.
14. Man M Q, Choi E H, Schmuth M. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol 2006, 126:386-392.
15. Schmuth M, Jiang Y J, Dubrac S, Elias P M, Feingold K R. Peroxisome proliferator-activated receptors (PPAR) and liver X receptors (LXR) in epidermal biology. J Lipid Res 2008, 49:499-509.
16. Michalik L, Wahli W. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochim Biophys Acta 2007, 1771:991-998.
17. Rivier M, Castiel I, Safonova I, Ailhaud G, Michel S. Peroxisome proliferator-activated receptor-α enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 2000, 114:681-687.
18. Brash A R, Yu Z, Boeglin W E, Schneider C. The hepoxilin connection in the epidermis. FEBS J 2007, 274:3494-3502.
19. Jobard F, Lefèvre C, Karaduman A. Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. Hum Mol Genet 2002, 11:107-113.
20. Eckl K M, Krieg P, Kuster W. Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis. Hum Mutat 2005, 26:351-361.
21. Sheehan D, Hrapchak B. Theory and Practice of Histotechnology 1980, In. St Louis, MO, CV Mosby Company
22. Törmä H, Lindberg M, Berne B. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008, 128:1212-1219.
23. Törmä H, Geijer S, Gester T, Alpholm K, Berne B, Lindberg M. Variations in the mRNA expression of inflammatory mediators, markers of differentiation and lipid-metabolizing enzymes caused by sodium lauryl sulphate in cultured human keratinocytes. Toxicol In Vitro 2006, 20:472-479.
24. Vandesompele J, De Preter K, Pattyn F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.0031-RESEARCH 0034.0011
25. Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 2002, 119:416-423.
26. Takagi Y, Nakagawa H, Yaginuma T, Takema Y, Imokawa G. An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function. Arch Dermatol Res 2005, 297:18-25.
27. Buraczewska I. Skin barrier responses to moisturizers. Digital comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 381 2008, Uppsala, Uppsala University
28. Schadinger S E, Bucher N L, Schreiber B M, Farmer S R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 2005, 288:E1195-E1205.
29. Demerjian M, Man M Q, Choi E H. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol 2006, 15:154-160.
30. Man M Q, Fowler A J, Schmuth M. Peroxisome-proliferator-activated receptor (PPAR)-γ activation stimulates keratinocyte differentiation. J Invest Dermatol 2004, 123:305-312.
31. Man M Q, Barish G D, Schmuth M. Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 2008, 128:370-377.
32. Wang Z, Boudjelal M, Kang S, Voorhees J J, Fisher G J. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med 1999, 5:418-422.
33. Boudjelal M, Voorhees J J, Fisher G J. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells. Exp Cell Res 2002, 274:130-137.
34. Andersson E, Rosdahl I, Törmä H, Vahlquist A. Differential effects of UV irradiation on nuclear retinoid receptor levels in cultured keratinocytes and melanocytes. Exp Dermatol 2003, 12:563-571.
35. Yu Z, Schneider C, Boeglin W E, Brash A R. Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARα. Lipids 2007, 42:491-497.
36. Guo L, Fang H, Collins J. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists. BMC Bioinformatics 2006, 7:S18.
37. Imakado S, Bickenbach J R, Bundman D S. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 1995, 9:317-329.
38. Schmuth M, Schoonjans K, Yu Q C. Role of peroxisome proliferator-activated receptor α in epidermal development in utero. J Invest Dermatol 2002, 119:1298-1303.
39. Segre J A, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 1999, 22:356-360.
40. Johnson E N, Nanney L B, Virmani J, Lawson J A, Funk C D. Basal transepidermal water loss is increased in platelet-type 12-lipoxygenase deficient mice. J Invest Dermatol 1999, 112:861-865.
41. Matsuki M, Yamashita F, Ishidayamamoto A. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A 1998, 95:1044-1049.
42. Tunggal J A, Helfrich I, Schmitz A. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 2005, 24:1146-1156.
43. Jennemann R, Sandhoff R, Langbein L. Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis. J Biol Chem 2007, 282:3083-3094.
44. Presland R B, Coulombe P A, Eckert R L, Mao-Qiang M, Feingold K R, Elias P M. Barrier function in transgenic mice overexpressing K16, involucrin, and filaggrin in the suprabasal epidermis. J Invest Dermatol 2004, 123:603-606.
45. Ny A, Egelrud T. Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme. Acta Derm Venereol 2004, 84:18-22.
46. Turksen K, Troy T C. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002, 129:1775-1784.